ArticleACS pharmacology & translational science2024
Novel Peripherally Selective Cannabinoid Receptor 1 Neutral Antagonist Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice.
Lucas T Laudermilk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.